Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6497) 6497
Book Chapter (226) 226
Conference Proceeding (97) 97
Dissertation (57) 57
Publication (24) 24
Web Resource (6) 6
Magazine Article (4) 4
Book / eBook (3) 3
Book Review (2) 2
Government Document (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (3344) 3344
life sciences & biomedicine (3178) 3178
humans (3085) 3085
drug interactions (2677) 2677
pharmacology & pharmacy (2309) 2309
drug-drug interaction (1799) 1799
drug-drug interactions (1664) 1664
animals (1587) 1587
male (1569) 1569
female (1061) 1061
pharmacokinetics (939) 939
receptors, drug - drug effects (779) 779
adult (760) 760
biological and medical sciences (704) 704
middle aged (675) 675
drug–drug interaction (672) 672
medical sciences (647) 647
rats (602) 602
drug–drug interactions (590) 590
pharmacology (556) 556
pharmacology. drug treatments (540) 540
aged (480) 480
analysis (453) 453
drugs (451) 451
toxicology (386) 386
cytochrome p450 (384) 384
dose-response relationship, drug (382) 382
drug interaction (370) 370
mice (319) 319
biochemistry & molecular biology (317) 317
young adult (309) 309
physical sciences (308) 308
chemistry (301) 301
drug therapy (298) 298
cytochrome p-450 (296) 296
area under curve (286) 286
drug therapy, combination (282) 282
kinetics (267) 267
metabolism (265) 265
cytochrome p-450 enzyme system - metabolism (262) 262
adolescent (261) 261
research (257) 257
complications and side effects (251) 251
in vitro techniques (245) 245
models, biological (238) 238
pharmacology/toxicology (230) 230
polypharmacy (220) 220
pharmacy (219) 219
enzymes (208) 208
metabolites (207) 207
receptors, drug - metabolism (207) 207
oncology (199) 199
drug dosages (198) 198
cross-over studies (194) 194
research article (192) 192
administration, oral (191) 191
patients (188) 188
risk factors (187) 187
physiological aspects (184) 184
pharmaceutical preparations - metabolism (183) 183
cytochrome p-450 cyp3a - metabolism (177) 177
medicine (177) 177
aged, 80 and over (175) 175
rats, sprague-dawley (174) 174
time factors (173) 173
drug metabolism (172) 172
cyp3a4 (168) 168
biomedicine (163) 163
liver (162) 162
infectious diseases (154) 154
chemistry, medicinal (152) 152
drug‐drug interaction (152) 152
medicine & public health (152) 152
pharmacodynamics (151) 151
cancer (150) 150
chemistry, multidisciplinary (150) 150
hiv (146) 146
neurosciences & neurology (146) 146
liver - metabolism (142) 142
hiv infections - drug therapy (141) 141
microsomes, liver - metabolism (141) 141
protein binding (138) 138
internal medicine (137) 137
side effects (136) 136
drug‐drug interactions (135) 135
cytochrome (133) 133
care and treatment (132) 132
enzyme inhibitors - pharmacology (131) 131
p-glycoprotein (131) 131
warfarin (131) 131
retrospective studies (130) 130
health aspects (129) 129
proteins (129) 129
dosage and administration (128) 128
microsomes, liver - drug effects (128) 128
drug synergism (127) 127
inhibition (123) 123
structure-activity relationship (123) 123
cells, cultured (120) 120
drug design (120) 120
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5068) 5068
Japanese (1320) 1320
Chinese (508) 508
German (50) 50
French (35) 35
Russian (32) 32
Spanish (14) 14
Portuguese (13) 13
Czech (10) 10
Slovenian (7) 7
Korean (6) 6
Italian (3) 3
Hungarian (2) 2
Polish (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
Swedish (1) 1
Thai (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral Drugs
by Kakuda, Thomas N and Schöller-Gyüre, Monika and Hoetelmans, Richard M. W
Clinical pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: A systematic review on CYP2C9, CYP2C19 and CYP2D6
by Bahar, Muh Akbar and Setiawan, Didik and Hak, Eelko and Wilffert, Bob
Pharmacogenomics, ISSN 1462-2416, 05/2017, Volume 18, Issue 7, pp. 701 - 739
drug-drug interaction (DDI) | CYP2C9 | drug-metabolizing enzyme | CYP2C19 | CYP2D6 | drug-drug-gene interaction (DDGI) | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cytochrome P-450 CYP2D6 - genetics | Pharmacogenetics - methods | Pharmacogenetics - trends | Animals | Drug Interactions - genetics | Humans | Cytochrome P-450 CYP2C19 - genetics | Cytochrome P-450 CYP2D6 - metabolism | Cytochrome P-450 CYP2C19 - metabolism | Inactivation, Metabolic - genetics | Cytochrome P-450 CYP2C9 - metabolism | Cytochrome P-450 CYP2C9 - genetics
Journal Article
Details down arrow
3. Full Text Drug–Drug Interaction Potential of Marketed Oncology Drugs: In Vitro Assessment of Time-Dependent Cytochrome P450 Inhibition, Reactive Metabolite Formation and Drug–Drug Interaction Prediction
by Kenny, Jane R and Mukadam, Sophie and Zhang, Chenghong and Tay, Suzanne and Collins, Carol and Galetin, Aleksandra and Khojasteh, S Cyrus
Pharmaceutical research, ISSN 0724-8741, 7/2012, Volume 29, Issue 7, pp. 1960 - 1976
Biomedical Engineering | Biochemistry, general | Biomedicine | kinase inhibitors | time-dependent CYP inhibition | Pharmacy | prediction | Medical Law | reactive metabolites | Pharmacology/Toxicology | drug-drug interaction | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Cytochrome P-450 Enzyme Inhibitors | Area Under Curve | Humans | Cytochrome P-450 Enzyme System - metabolism | Antineoplastic Agents - chemistry | Blood Proteins - metabolism | Neoplasms - drug therapy | Antineoplastic Agents - metabolism | Protein Kinase Inhibitors - chemistry | Drug Interactions | Microsomes, Liver - drug effects | Models, Biological | Antineoplastic Agents - pharmacology | Microsomes, Liver - enzymology | Protein Kinase Inhibitors - pharmacology | Protein Kinase Inhibitors - metabolism | Drugs | Physiological aspects | Enzymes | Metabolites | Drug interactions | Cytochrome P-450 | Drug therapy | Oncology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Comparative analysis of three drug–drug interaction screening systems against probable clinically relevant drug–drug interactions: a prospective cohort study
by Muhič, Neža and Mrhar, Ales and Brvar, Miran
European journal of clinical pharmacology, ISSN 0031-6970, 07/2017, Volume 73, Issue 7, pp. 875 - 882
Drug–drug interaction screening systems | Adverse drug reactions | Potential drug–drug interactions | Actual drug–drug interactions | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Drug Interactions | Drug-Related Side Effects and Adverse Reactions - prevention & control | Prospective Studies | Humans | Hospitalization - statistics & numerical data | Female | Male | Aged | Drug Information Services | Tertiary Care Centers - statistics & numerical data | Medicine, Experimental | Medical research | Comparative analysis | Drug interactions | Drugs | Sensitivity analysis | Toxicity | Digitalis | Systems analysis | Medical screening | Patients | Bleeding | Hypotension | Screening | Side effects | Sensitivity | Hyperkalemia | Drug interaction | Internet | Health risk assessment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text SFINX - A drug-drug interaction database designed for clinical decision support systems
by Böttiger, Ylva and Laine, Kari and Andersson, Marine L and Korhonen, Tuomas and Molin, Björn and Ovesjö, Marie-Louise and Tirkkonen, Tuire and Rane, Anders and Gustafsson, Lars L and Eiermann, Birgit
European journal of clinical pharmacology, ISSN 0031-6970, 06/2009, Volume 65, Issue 6, pp. 627 - 633
Clinical decision support system | Drug-drug interaction database | Drug interactions | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Decision Support Systems, Clinical | Database Management Systems | Drug Interactions | Decision support systems | Prescription writing | Databases | Pharmacists | Pharmacology | Drug therapy | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
by Prueksaritanont, Thomayant and Chu, Xiaoyan and Gibson, Christopher and Cui, Donghui and Yee, Ka Lai and Ballard, Jeanine and Cabalu, Tamara and Hochman, Jerome
The AAPS journal, ISSN 1550-7416, 7/2013, Volume 15, Issue 3, pp. 629 - 645
Biochemistry, general | Biotechnology | Biomedicine | Pharmacy | drug–drug interaction studies | regulatory guidance | Pharmacology/Toxicology | industry perspective | drug-drug interaction studies | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pharmaceutical Preparations - metabolism | Animals | Pharmaceutical Preparations - standards | European Union | Practice Guidelines as Topic - standards | United States | Humans | United States Food and Drug Administration - standards | Drug Interactions - physiology | United States Food and Drug Administration - legislation & jurisprudence | Physiological aspects | Enzymes | Invisibility | Analysis | Drug interactions | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Interaction between warfarin and cannabis
by Damkier, Per and Lassen, Dorte and Christensen, Mette Marie Hougaard and Madsen, Kenneth Grønkjær and Hellfritzsch, Maja and Pottegård, Anton
Basic & clinical pharmacology & toxicology, ISSN 1742-7835, 01/2019, Volume 124, Issue 1, pp. 28 - 31
cannabis | case report | MiniReview | drug‐drug interaction | warfarin | drug-drug interaction | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Marijuana Smoking - adverse effects | Stroke - prevention & control | Humans | Anticoagulants - therapeutic use | Male | Substance-Related Disorders - complications | Warfarin - pharmacology | Warfarin - therapeutic use | International Normalized Ratio | Stroke - blood | Cannabis - chemistry | Stroke - etiology | Cytochrome P-450 CYP2C9 Inhibitors - pharmacology | Drug Interactions | Heart Valve Prosthesis Implantation - adverse effects | Anticoagulants - pharmacology | Adult | Dronabinol - pharmacology | Cytochrome P-450 CYP2C9 - metabolism | Endocarditis - surgery | Cytochrome | Drug abuse | Enzymes | Warfarin | Epilepsy | Cytochrome P450 | Drug interactions | Case reports | Metabolism | Patients | Heart valves | Substrates | Bleeding | Literature reviews | Case studies | Cannabis | Recreational use | Cannabinoids | Marijuana | Drug interaction | Tetrahydrocannabinol | Cytochromes P450 | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Predicting Drug–Drug Interactions: An FDA Perspective
by Zhang, Lei and Zhang, Yuanchao (Derek) and Zhao, Ping and Huang, Shiew-Mei
The AAPS journal, ISSN 1550-7416, 6/2009, Volume 11, Issue 2, pp. 300 - 306
Biochemistry, general | Biotechnology | Biomedicine | drug–drug interaction | Pharmacy | drug development | prediction | new drug application | Pharmacology/Toxicology | regulatory and guidance | New drug application | Regulatory and guidance | Drug development | Drug-drug interaction | Prediction | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Guidelines as Topic | Pharmaceutical Preparations - metabolism | Animals | Carrier Proteins - metabolism | Drug Interactions | United States | Computer Simulation | Humans | Pharmacokinetics | Forecasting | United States Food and Drug Administration | Physiological aspects | Enzymes | Drug interactions | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Potential metabolic drug-drug interaction of Citrus aurantium L. (Rutaceae) evaluating by its effect on 3 CYP450
by Zhou, Lu and Cui, Man and Zhao, Linlin and Wang, Dongsheng and Tang, Tao and Wang, Wenbo and Wang, Sheng and Huang, Huiyong and Qiu, Xinjian
Frontiers in pharmacology, ISSN 1663-9812, 08/2018, Volume 9, pp. 895 - 895
CYP2E1 | CYP3A4 | Drug-drug interaction | Fructus aurantii | CYP1A2 | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Bitter orange | Drug interactions | Analysis | Cytochrome P-450 | Research | Properties | Gene expression | Pharmacology | drug–drug interaction
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights